Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?
Masimo's (MASI) shares have risen year to date on the back of strong fundamentals. However, rising costs can be a cause of concern.
Is Masimo (MASI) Stock Outpacing Its Medical Peers This Year?
Here is how Masimo (MASI) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.
Masimo (MASI) Plans Consumer Business Spin-Off to Drive Growth
Masimo (MASI) is evaluating a proposed separation of its consumer audio and consumer health product business in a bid to improve the profitability of the healthcare business.
Masimo (MASI) Soars 3.3%: Is Further Upside Left in the Stock?
Masimo (MASI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r...
Masimo CEO on potential split, proxy battle and spinning off consumer business
Joe Kiani, Masimo CEO, joins 'Closing Bell: Overtime' to discuss the company spinning off its consumer business.
Activist investor plans second fight at Masimo, sending shares up 12%
Quentin Koffey's Politan Capital waged a successful proxy fight at Masimo last year, and it is now seeking two more board seats.
Masimo's stock rallies on report of looming activist campaign, disclosure of spinoff plan
Masimo Corp.'s stock MASI, +1.40% was up 12% in premarket trading on Monday after The Wall Street Journal reported that activist investor Politan Capital Management plans to nominate two more membe...
Masimo Stock Surges After Proposed Spinoff of Consumer Business
Share in Masimo (MASI) surged 13% in extended trading on Friday after the company announced that it is planning a spinoff of its consumer unit to improve the profitability of its primary healthcare...
Activist investor Politan plans second proxy battle at Masimo, WSJ reports
Activist investor Politan Capital Management, which last year won two seats on the board of medical technology company Masimo Corp , is planning a second proxy battle for two more seats, the Wall S...
Masimo plans to spinoff consumer business
Medical technology company Masimo Corp said on Friday it is evaluating a proposed spinoff of its consumer business, which includes its consumer health and audio products, sending shares up 13% in e...
Masimo (MASI) Q4 Earnings Beat Estimates, Margins Decline
Despite strength in the Hearables category, Masimo's (MASI) overall fourth-quarter results reflect soft performances.
Masimo (MASI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Masimo (MASI) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street est...
Masimo (MASI) Beats Q4 Earnings and Revenue Estimates
Masimo (MASI) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $1.32 per share a year ago.
Are Medical Stocks Lagging Masimo (MASI) This Year?
Here is how Masimo (MASI) and CochLear Ltd. Unsponsored ADR (CHEOY) have performed compared to their sector so far this year.
Related Companies